Plasminogen Activator, Urokinase (PLAU) Peptide
-
- Target See all PLAU products
- PLAU (Plasminogen Activator, Urokinase (PLAU))
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Immunogen (Imm)
- Sequence
- HFLPWIRSHT KEEN
- Characteristics
- The peptide was used in the production of ABIN369154 - Goat Anti-Plasminogen Activator / PLAU Antibody. It is currently untested in blocking applications.
-
-
- Application Notes
- When peptides are reconstituted in 200ul water, the concentration would be also 0.5mg/ml. To start, the best ratio would be 1:1 (which means molar excess of peptides relative to antibodies when identical volumes are mixed). Please mix equal volumes of peptide and antibody at the required dilution and leave at ambient temperature. Best is to have two identical blots, to be incubated with equal amount of antibodies, but one with the antibodies pre-adsorbed to the peptide for 20min. Then incubate and develop in parallel the two blots.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Reconstitute pellet in distilled water where required. For Blocking studies, reconstitute pellet in 200µl distilled water to obtain a 0.5mg/ml peptide solution.
- Buffer
- 100µg of Lyophilised peptide, formulation De-ionized (DI) water.
- Storage
- -20 °C
- Storage Comment
- Shipped at ambient temperature, store at -20°C.
-
- Target
- PLAU (Plasminogen Activator, Urokinase (PLAU))
- Synonyms
- PLAU Peptide, u-PA Peptide, ATF Peptide, BDPLT5 Peptide, QPD Peptide, UPA Peptide, URK Peptide, uPA Peptide, UPAM Peptide, plasminogen activator, urokinase Peptide, urokinase-type plasminogen activator Peptide, PLAU Peptide, CpipJ_CPIJ002131 Peptide, CpipJ_CPIJ006543 Peptide, CpipJ_CPIJ013396 Peptide, CpipJ_CPIJ013623 Peptide, Plau Peptide
-